Visit ClinicalTrials.gov
For more information about the LIFE-BTK study.
The study, called LIFE-BTK, is assessing the safety and effectiveness of Abbott's new Esprit™ BTK scaffold. Patient enrollment is complete for the LIFE-BTK clinical study and LIFE-BTK PK Sub-Study. The Esprit™ BTK is designed to treat blocked arteries below the knee, or critical limb ischemia, in people battling advanced stages of disease of the arteries outside of the heart, called peripheral artery disease (PAD).
Help is available to ensure patients can return for the follow-up:
As seen on Access Health airing on Lifetime Television‡: